- Stocks
- Pages
- Blogs
- Research Reports
sink_data

View

app landing page

View

bse

View

nse

View

Holiday

View

blog author

View

Author

View

Research Baskets

View

high stocks test page

View

MF_API

View

What is a Demat Account? Meaning, Benefits, Types & How It Works
4 September 2026
Read Blog

What is Mutual Fund: Definition, Benefits & How to Invest in it 
3 September 2026
Read Blog

What is an IPO? Full Form, Meaning & How It Works
2 September 2026
Read Blog

Portfolio Allocation Strategy During Interest Rate Cycles
30 June 2026
Read Blog

What happens after a company gets delisted?
19 June 2026
Read Blog

FII vs DII: Key Differences Explained
16 June 2026
Read Blog

What Is REIT?
15 June 2026
Read Blog

Difference Between Bull and Bear Market
12 June 2026
Read Blog

What is IOC in Share Market?
11 June 2026
Read Blog

What Is a Short Delivery in Share Market?
10 June 2026
Read Blog

View All Blogs

Asset Management Companies – Sector Update – Fragmentation increasing in the AMC sector
18 September 2026
Read Report

Coforge (COFORGE IN) – Event Update – Accelerating AI stack to scale production – BUY
18 September 2026
Read Report

Power – Sector Update – Transmission: PWGR leads near-term execution visibility
17 September 2026
Read Report

Cyient DLM (CYIENTDL IN) – Visit Update – Focus on B2S & new-age electronics to drive growth – HOLD
17 September 2026
Read Report

The Beat – DCX Systems set for a booming upside!
02 January 2025
Read Report

Technical Newsletter: 17-Sept-2026
17 September 2026
Read Report

JSW Steel (JSTL IN) – Q3FY25 Result Update – Better quarter, but HRC situation yet to improve – HOLD
27 January 2025
Read Report

Technical Newsletter: 16-Sept-2026
16 September 2026
Read Report

ICICI Bank (ICICIBC IN) – Q3FY25 Result Update – Asset quality remains best-in-class – BUY
27 January 2025
Read Report

Consumer Durables – Sector Update – RAC leads rebound, margins remain muted
16 September 2026
Read Report

View All Reports
Login
Open Account

Aspira Pathlab & Diagnostics Ltd

Q: What is the current share price of Aspira Pathlab & Diagnostics Ltd?

As of 18-Sep-2026, 16:01:22 the share price for Aspira Pathlab & Diagnostics Ltd. is ₹ 115 on the NSE (Note: Prices are dynamic and update frequently during market hours).

Small Cap | Healthcare

₹ 115 5.47(4.99%)

Last updated: 18-Sep-2026 , 16:01:22

Aspira Pathlab & Diagnostics Ltd Price Today Aspira Pathlab & Diagnostics Ltd share price is ₹115 as on 18-Sep-2026, Up 4.99% from the previous close of ₹109.53. The stock has traded between ₹115 and ₹115 today, against a 52-week range of ₹49 to ₹135.88. Over the past year the stock is Up 177.31% range. Market capitalisation stands at ₹93.87 crore.

Aspira Pathlab & Diagnostics Ltd Live Price Chart

Fundamental
Performance
Financials
Share Holding Pattern
About Company

Performance

Low: ₹115 High: 115

Previous Close	₹ 109.53
High	₹ 115
Volume	87
52W Range	₹ 49 - ₹ 135.88

Open	₹ 115
Low	₹ 115
Market Cap	₹ 93.87 Cr

Aspira Pathlab & Diagnostics Ltd Technicals

Current Price

₹ 115 5.47 (4.99%)

EMASMA

20 Day	₹ 99.380
50 Day	₹ 100.129
100 Day	₹ 97.004
200 Day	₹ 88.070

20 Day	₹ 95.316
50 Day	₹ 99.362
100 Day	₹ 103.583
200 Day	₹ 82.726

Aspira Pathlab & Diagnostics Ltd Fundamentals

ROCE	2.834
P/E Ratio	-261.360
P/B Ratio	9.680
Industry P/E	9.680
Debt to Equity	92.438

ROE	0.419
EPS	-0.440
Dividend Yield	0.000
Book Value	11.885
Face Value	10.000

Aspira Pathlab & Diagnostics Ltd Financials

Particulars	Y202503	Y202403	Y202303	Y202203	Y202103
Total Revenue	22.3879	13.626	14.7778	19.6366	15.4092
Total Expenses	20.3153	16.2982	14.8665	15.1772	14.0282
Profit After Tax	2.0726	-2.6722	-0.0887	4.4594	1.381

Aspira Pathlab & Diagnostics Ltd Shareholding Pattern

Promoter Holdings	46.583 %
FIIs	0.000 %
DIIs	0.000 %
MutualFund	0.000 %
Retail	40.698 %
Others -	12.719 %

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results. During the year 2016, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving websit ...

Similar Stocks

Apollo Hospitals Enterprise Ltd Healthcare	₹ 8,770.25 +20.25 (+0.23%)
Surlux Diagnostic Ltd Healthcare	-
Chennai Meenakshi Multispeciality Hospital Ltd Healthcare	₹ 38.60 +0.09 (+0.23%)
Kovai Medical Center & Hospital Ltd Healthcare	₹ 6,296.65 +155.9 (+2.54%)
Fortis Malar Hospitals Ltd Healthcare	₹ 41.95 +0.64 (+1.55%)
Shree Pacetronix Ltd Healthcare	₹ 158.45 +10.2 (+6.88%)

FAQs on Aspira Pathlab & Diagnostics Ltd

1. Can I buy Aspira Pathlab & Diagnostics Ltd from PL Capital? ›

Yes, you can invest in Aspira Pathlab & Diagnostics Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aspira Pathlab & Diagnostics Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aspira Pathlab & Diagnostics Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Aspira Pathlab & Diagnostics Ltd pay dividends? ›

Aspira Pathlab & Diagnostics Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Aspira Pathlab & Diagnostics Ltd ? ›

As of 18-Sep-2026 , 16:01:22 the share price for Aspira Pathlab & Diagnostics Ltd. is ₹ 115 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Aspira Pathlab & Diagnostics Ltd ? ›

The 52-week high and low of Aspira Pathlab & Diagnostics Ltd share price is ₹ 49 - ₹ 135.88 as of 18-Sep-2026 , 16:01:22 .

5. What is the market capitalisation of Aspira Pathlab & Diagnostics Ltd? ›

Market capitalisation of Aspira Pathlab & Diagnostics Ltd is ₹93.87Cr as of 18-Sep-2026.

6. What is the current P/E ratio of Aspira Pathlab & Diagnostics Ltd? ›

The P/E (price-to-earnings) ratio of Aspira Pathlab & Diagnostics Ltd is -261.360.

7. What is the current P/B ratio of Aspira Pathlab & Diagnostics Ltd? ›

The P/B (price-to-book) ratio of Aspira Pathlab & Diagnostics Ltd is 9.680.

8. What is the shareholding pattern of Aspira Pathlab & Diagnostics Ltd? ›

As of 18-Sep-2026, promoters hold 46.583%, foreign institutional investors hold 0.000%, domestic institutional investors hold 0.000%, and the public holds 40.698%.